Raras
Buscar doenças, sintomas, genes...
Síndrome Zellweger
ORPHA:912CID-10 · Q87.8CID-11 · 5C57.0DOENÇA RARA

É a forma mais grave das doenças relacionadas à formação dos peroxissomos. Caracteriza-se por problemas na migração das células nervosas no cérebro, alterações na forma do rosto e da cabeça, fraqueza muscular intensa, convulsões em recém-nascidos e problemas no funcionamento do fígado.

Mantido por Agente Raras·Colaborar como especialista →

Introdução

O que você precisa saber de cara

📋

É a forma mais grave das doenças relacionadas à formação dos peroxissomos. Caracteriza-se por problemas na migração das células nervosas no cérebro, alterações na forma do rosto e da cabeça, fraqueza muscular intensa, convulsões em recém-nascidos e problemas no funcionamento do fígado.

Pesquisas ativas
2 ensaios
11 total registrados no ClinicalTrials.gov
Publicações científicas
788 artigos
Último publicado: 2026

Escala de raridade

CLASSIFICAÇÃO ORPHANET · BRASIL 2024
Unknown
Ultra-rara
<1/50k
Muito rara
1/20k
Rara
1/10k
Pouco freq.
1/5k
Incomum
1/2k
Prevalência
0.0
Worldwide
Início
Neonatal
🏥
SUS: Cobertura mínimaScore: 15%
CID-10: Q87.8
🇧🇷Dados SUS / DATASUS
PROCEDIMENTOS SIGTAP (5)
0202010503
Cariótipo — bandas G, Q ou Rgenetic_test
0202010600
Pesquisa de microdeleções/microduplicações por FISHlab_test
0202010694
Sequenciamento completo do exoma (WES)rehabilitation
0202010260
Dosagem de alfa-fetoproteína
0301070040
Atendimento em reabilitação — doenças raras
Você se identifica com essa condição?
O Raras está aqui pra te apoiar — com ou sem diagnóstico

Encontrou um erro ou informação desatualizada? Sugira uma correção →

Entender a doença

Do básico ao detalhe, leia no seu ritmo

Preparando trilha educativa...

Sinais e sintomas

O que aparece no corpo e com que frequência cada sintoma acontece

Partes do corpo afetadas

🧠
Neurológico
51 sintomas
👁️
Olhos
29 sintomas
😀
Face
28 sintomas
🦴
Ossos e articulações
17 sintomas
🫃
Digestivo
15 sintomas
🫘
Rins
11 sintomas

+ 141 sintomas em outras categorias

Características mais comuns

90%prev.
Reflexos tendíneos reduzidos
Muito frequente (99-80%)
90%prev.
Morte na infância
90%prev.
Anormalidade no EEG
Muito frequente (99-80%)
90%prev.
Insuficiência hepática
Muito frequente (99-80%)
90%prev.
Displasia esquelética
Muito frequente (99-80%)
90%prev.
Dificuldades alimentares na infância
Muito frequente (99-80%)
336sintomas
Muito frequente (25)
Frequente (23)
Ocasional (7)
Sem dados (281)

Os sintomas variam de pessoa para pessoa. Abaixo estão as 336 características clínicas mais associadas, ordenadas por frequência.

Reflexos tendíneos reduzidosReduced tendon reflexes
Muito frequente (99-80%)90%
Morte na infânciaDeath in infancy
Muito frequente90%
Anormalidade no EEGEEG abnormality
Muito frequente (99-80%)90%
Insuficiência hepáticaHepatic failure
Muito frequente (99-80%)90%
Displasia esqueléticaSkeletal dysplasia
Muito frequente (99-80%)90%

Linha do tempo da pesquisa

Publicações por ano — veja quando o interesse científico cresceu
Anos de pesquisa1desde 2026
Total histórico788PubMed
Últimos 10 anos200publicações
Pico201825 papers
Linha do tempo
2026Hoje · 2026🧪 1992Primeiro ensaio clínico📈 2018Ano de pico
Publicações por ano (últimos 10 anos)

Encontrou um erro ou informação desatualizada? Sugira uma correção →

Genética e causas

O que está alterado no DNA e como passa nas famílias

Genes associados

14 genes identificados com associação a esta condição. Padrão de herança: Autosomal recessive.

PEX16Peroxisomal membrane protein PEX16Disease-causing germline mutation(s) inTolerante
FUNÇÃO

Required for peroxisome membrane biogenesis. May play a role in early stages of peroxisome assembly. Can recruit other peroxisomal proteins, such as PEX3 and PMP34, to de novo peroxisomes derived from the endoplasmic reticulum (ER). May function as receptor for PEX3

LOCALIZAÇÃO

Peroxisome membrane

VIAS BIOLÓGICAS (1)
Class I peroxisomal membrane protein import
MECANISMO DE DOENÇA

Peroxisome biogenesis disorder complementation group 9

A peroxisomal disorder arising from a failure of protein import into the peroxisomal membrane or matrix. The peroxisome biogenesis disorders (PBD group) are genetically heterogeneous with at least 14 distinct genetic groups as concluded from complementation studies. Include disorders are: Zellweger syndrome (ZWS), neonatal adrenoleukodystrophy (NALD), infantile Refsum disease (IRD), and classical rhizomelic chondrodysplasia punctata (RCDP). ZWS, NALD and IRD are distinct from RCDP and constitute a clinical continuum of overlapping phenotypes known as the Zellweger spectrum (PBD-ZSS).

EXPRESSÃO TECIDUAL(Ubíquo)
Pituitária
31.4 TPM
Testículo
30.9 TPM
Tireoide
24.5 TPM
Nervo tibial
23.1 TPM
Brain Spinal cord cervical c-1
22.4 TPM
OUTRAS DOENÇAS (5)
peroxisome biogenesis disorder 8A (Zellweger)peroxisome biogenesis disorder 8BZellweger spectrum disordersobsolete neonatal adrenoleukodystrophy
HGNC:8857UniProt:Q9Y5Y5
PEX7Peroxisomal targeting signal 2 receptorDisease-causing germline mutation(s) inTolerante
FUNÇÃO

Receptor required for the peroxisomal import of proteins containing a C-terminal PTS2-type peroxisomal targeting signal (PubMed:11931631, PubMed:22057399, PubMed:25538232, PubMed:9090381). Specifically binds to cargo proteins containing a PTS2 peroxisomal targeting signal in the cytosol (PubMed:11931631, PubMed:22057399, PubMed:25538232). Cargo protein-binding triggers interaction with PEX5 and formation of a ternary complex composed of PEX5 and PEX7 along with PTS2-containing cargo proteins, wh

LOCALIZAÇÃO

Cytoplasm, cytosolPeroxisome matrix

VIAS BIOLÓGICAS (1)
Peroxisomal protein import
MECANISMO DE DOENÇA

Peroxisome biogenesis disorder complementation group 11

A peroxisomal disorder arising from a failure of protein import into the peroxisomal membrane or matrix. The peroxisome biogenesis disorders (PBD group) are genetically heterogeneous with at least 14 distinct genetic groups as concluded from complementation studies. Include disorders are: Zellweger syndrome (ZWS), neonatal adrenoleukodystrophy (NALD), infantile Refsum disease (IRD), and classical rhizomelic chondrodysplasia punctata (RCDP). ZWS, NALD and IRD are distinct from RCDP and constitute a clinical continuum of overlapping phenotypes known as the Zellweger spectrum (PBD-ZSS).

EXPRESSÃO TECIDUAL(Ubíquo)
Testículo
20.5 TPM
Glândula adrenal
18.8 TPM
Skin Sun Exposed Lower leg
17.0 TPM
Skin Not Sun Exposed Suprapubic
16.2 TPM
Estômago
14.2 TPM
OUTRAS DOENÇAS (3)
peroxisome biogenesis disorder 9Brhizomelic chondrodysplasia punctata type 1adult Refsum disease
HGNC:8860UniProt:O00628
PEX12Peroxisome assembly protein 12Disease-causing germline mutation(s) inTolerante
FUNÇÃO

Component of a retrotranslocation channel required for peroxisome organization by mediating export of the PEX5 receptor from peroxisomes to the cytosol, thereby promoting PEX5 recycling (PubMed:24662292, PubMed:9354782, PubMed:9632816). The retrotranslocation channel is composed of PEX2, PEX10 and PEX12; each subunit contributing transmembrane segments that coassemble into an open channel that specifically allows the passage of PEX5 through the peroxisomal membrane (By similarity). PEX12 also re

LOCALIZAÇÃO

Peroxisome membrane

VIAS BIOLÓGICAS (3)
Peroxisomal protein importE3 ubiquitin ligases ubiquitinate target proteinsClass I peroxisomal membrane protein import
MECANISMO DE DOENÇA

Peroxisome biogenesis disorder complementation group 3

A peroxisomal disorder arising from a failure of protein import into the peroxisomal membrane or matrix. The peroxisome biogenesis disorders (PBD group) are genetically heterogeneous with at least 14 distinct genetic groups as concluded from complementation studies. Include disorders are: Zellweger syndrome (ZWS), neonatal adrenoleukodystrophy (NALD), infantile Refsum disease (IRD), and classical rhizomelic chondrodysplasia punctata (RCDP). ZWS, NALD and IRD are distinct from RCDP and constitute a clinical continuum of overlapping phenotypes known as the Zellweger spectrum (PBD-ZSS).

EXPRESSÃO TECIDUAL(Ubíquo)
Testículo
12.5 TPM
Fibroblastos
11.2 TPM
Pituitária
10.1 TPM
Glândula adrenal
9.2 TPM
Nervo tibial
9.2 TPM
OUTRAS DOENÇAS (4)
peroxisome biogenesis disorder type 3Bperoxisome biogenesis disorder 3A (Zellweger)Zellweger spectrum disordersobsolete neonatal adrenoleukodystrophy
HGNC:8854UniProt:O00623
PEX2Peroxisome biogenesis factor 2Disease-causing germline mutation(s) inTolerante
FUNÇÃO

E3 ubiquitin-protein ligase component of a retrotranslocation channel required for peroxisome organization by mediating export of the PEX5 receptor from peroxisomes to the cytosol, thereby promoting PEX5 recycling (PubMed:24662292). The retrotranslocation channel is composed of PEX2, PEX10 and PEX12; each subunit contributing transmembrane segments that coassemble into an open channel that specifically allows the passage of PEX5 through the peroxisomal membrane (By similarity). PEX2 also regulat

LOCALIZAÇÃO

Peroxisome membrane

VIAS BIOLÓGICAS (3)
Peroxisomal protein importE3 ubiquitin ligases ubiquitinate target proteinsClass I peroxisomal membrane protein import
MECANISMO DE DOENÇA

Peroxisome biogenesis disorder complementation group 5

A peroxisomal disorder arising from a failure of protein import into the peroxisomal membrane or matrix. The peroxisome biogenesis disorders (PBD group) are genetically heterogeneous with at least 14 distinct genetic groups as concluded from complementation studies. Include disorders are: Zellweger syndrome (ZWS), neonatal adrenoleukodystrophy (NALD), infantile Refsum disease (IRD), and classical rhizomelic chondrodysplasia punctata (RCDP). ZWS, NALD and IRD are distinct from RCDP and constitute a clinical continuum of overlapping phenotypes known as the Zellweger spectrum (PBD-ZSS).

EXPRESSÃO TECIDUAL(Ubíquo)
Linfócitos
32.1 TPM
Cervix Ectocervix
23.1 TPM
Útero
22.3 TPM
Nervo tibial
21.1 TPM
Tireoide
20.4 TPM
OUTRAS DOENÇAS (5)
peroxisome biogenesis disorder 5A (Zellweger)peroxisome biogenesis disorder 5BZellweger spectrum disordersobsolete neonatal adrenoleukodystrophy
HGNC:9717UniProt:P28328
PEX19Peroxisomal biogenesis factor 19Disease-causing germline mutation(s) inTolerante
FUNÇÃO

Necessary for early peroxisomal biogenesis. Acts both as a cytosolic chaperone and as an import receptor for peroxisomal membrane proteins (PMPs). Binds and stabilizes newly synthesized PMPs in the cytoplasm by interacting with their hydrophobic membrane-spanning domains, and targets them to the peroxisome membrane by binding to the integral membrane protein PEX3. Excludes CDKN2A from the nucleus and prevents its interaction with MDM2, which results in active degradation of TP53

LOCALIZAÇÃO

CytoplasmPeroxisome membrane

VIAS BIOLÓGICAS (3)
ABC transporters in lipid homeostasisDengue Virus-Host InteractionsClass I peroxisomal membrane protein import
MECANISMO DE DOENÇA

Peroxisome biogenesis disorder complementation group 14

A peroxisomal disorder arising from a failure of protein import into the peroxisomal membrane or matrix. The peroxisome biogenesis disorders (PBD group) are genetically heterogeneous with at least 14 distinct genetic groups as concluded from complementation studies. Include disorders are: Zellweger syndrome (ZWS), neonatal adrenoleukodystrophy (NALD), infantile Refsum disease (IRD), and classical rhizomelic chondrodysplasia punctata (RCDP). ZWS, NALD and IRD are distinct from RCDP and constitute a clinical continuum of overlapping phenotypes known as the Zellweger spectrum (PBD-ZSS).

EXPRESSÃO TECIDUAL(Ubíquo)
Tecido adiposo
67.4 TPM
Adipose Visceral Omentum
60.0 TPM
Mama
57.5 TPM
Ovário
56.4 TPM
Artéria tibial
55.3 TPM
OUTRAS DOENÇAS (3)
peroxisome biogenesis disorder 12A (Zellweger)Zellweger spectrum disordersobsolete neonatal adrenoleukodystrophy
HGNC:9713UniProt:P40855
PEX3Peroxisomal biogenesis factor 3Disease-causing germline mutation(s) inTolerante
FUNÇÃO

Involved in peroxisome biosynthesis and integrity. Assembles membrane vesicles before the matrix proteins are translocated. As a docking factor for PEX19, is necessary for the import of peroxisomal membrane proteins in the peroxisomes

LOCALIZAÇÃO

Peroxisome membrane

VIAS BIOLÓGICAS (2)
ABC transporters in lipid homeostasisClass I peroxisomal membrane protein import
MECANISMO DE DOENÇA

Peroxisome biogenesis disorder complementation group 12

A peroxisomal disorder arising from a failure of protein import into the peroxisomal membrane or matrix. The peroxisome biogenesis disorders (PBD group) are genetically heterogeneous with at least 14 distinct genetic groups as concluded from complementation studies. Include disorders are: Zellweger syndrome (ZWS), neonatal adrenoleukodystrophy (NALD), infantile Refsum disease (IRD), and classical rhizomelic chondrodysplasia punctata (RCDP). ZWS, NALD and IRD are distinct from RCDP and constitute a clinical continuum of overlapping phenotypes known as the Zellweger spectrum (PBD-ZSS).

EXPRESSÃO TECIDUAL(Ubíquo)
Glândula adrenal
48.7 TPM
Linfócitos
27.7 TPM
Fibroblastos
22.6 TPM
Esôfago - Mucosa
22.3 TPM
Testículo
22.1 TPM
OUTRAS DOENÇAS (4)
peroxisome biogenesis disorder 10Bperoxisome biogenesis disorder 10A (Zellweger)obsolete neonatal adrenoleukodystrophyZellweger spectrum disorders
HGNC:8858UniProt:P56589
PEX6Peroxisomal ATPase PEX6Disease-causing germline mutation(s) inTolerante
FUNÇÃO

Component of the PEX1-PEX6 AAA ATPase complex, a protein dislocase complex that mediates the ATP-dependent extraction of the PEX5 receptor from peroxisomal membranes, an essential step for PEX5 recycling (PubMed:16314507, PubMed:16854980, PubMed:21362118, PubMed:29884772). Specifically recognizes PEX5 monoubiquitinated at 'Cys-11', and pulls it out of the peroxisome lumen through the PEX2-PEX10-PEX12 retrotranslocation channel (PubMed:29884772). Extraction by the PEX1-PEX6 AAA ATPase complex is

LOCALIZAÇÃO

Cytoplasm, cytosolPeroxisome membraneCell projection, cilium, photoreceptor outer segment

VIAS BIOLÓGICAS (1)
Peroxisomal protein import
MECANISMO DE DOENÇA

Peroxisome biogenesis disorder complementation group 4

A peroxisomal disorder arising from a failure of protein import into the peroxisomal membrane or matrix. The peroxisome biogenesis disorders (PBD group) are genetically heterogeneous with at least 14 distinct genetic groups as concluded from complementation studies. Include disorders are: Zellweger syndrome (ZWS), neonatal adrenoleukodystrophy (NALD), infantile Refsum disease (IRD), and classical rhizomelic chondrodysplasia punctata (RCDP). ZWS, NALD and IRD are distinct from RCDP and constitute a clinical continuum of overlapping phenotypes known as the Zellweger spectrum (PBD-ZSS).

EXPRESSÃO TECIDUAL(Ubíquo)
Fallopian Tube
66.8 TPM
Ovário
64.6 TPM
Cerebelo
61.1 TPM
Cérebro - Hemisfério cerebelar
58.5 TPM
Pituitária
55.1 TPM
OUTRAS DOENÇAS (6)
peroxisome biogenesis disorder 4Bperoxisome biogenesis disorder 4A (Zellweger)peroxisome biogenesis disorder due to PEX6 defectobsolete Heimler syndrome
HGNC:8859UniProt:Q13608
PEX14Peroxisomal membrane protein PEX14Disease-causing germline mutation(s) inAltamente restrito
FUNÇÃO

Component of the PEX13-PEX14 docking complex, a translocon channel that specifically mediates the import of peroxisomal cargo proteins bound to PEX5 receptor (PubMed:24235149, PubMed:28765278, PubMed:9653144). The PEX13-PEX14 docking complex forms a large import pore which can be opened to a diameter of about 9 nm (By similarity). Mechanistically, PEX5 receptor along with cargo proteins associates with the PEX14 subunit of the PEX13-PEX14 docking complex in the cytosol, leading to the insertion

LOCALIZAÇÃO

Peroxisome membrane

VIAS BIOLÓGICAS (3)
Peroxisomal protein importE3 ubiquitin ligases ubiquitinate target proteinsClass I peroxisomal membrane protein import
MECANISMO DE DOENÇA

Peroxisome biogenesis disorder complementation group K

A peroxisomal disorder arising from a failure of protein import into the peroxisomal membrane or matrix. The peroxisome biogenesis disorders (PBD group) are genetically heterogeneous with at least 14 distinct genetic groups as concluded from complementation studies. Include disorders are: Zellweger syndrome (ZWS), neonatal adrenoleukodystrophy (NALD), infantile Refsum disease (IRD), and classical rhizomelic chondrodysplasia punctata (RCDP). ZWS, NALD and IRD are distinct from RCDP and constitute a clinical continuum of overlapping phenotypes known as the Zellweger spectrum (PBD-ZSS).

EXPRESSÃO TECIDUAL(Ubíquo)
Bladder
54.7 TPM
Próstata
39.8 TPM
Útero
31.9 TPM
Brain Frontal Cortex BA9
30.1 TPM
Testículo
29.2 TPM
OUTRAS DOENÇAS (3)
peroxisome biogenesis disorder 13A (Zellweger)Zellweger spectrum disordersobsolete neonatal adrenoleukodystrophy
HGNC:8856UniProt:O75381
PEX10Peroxisome biogenesis factor 10Disease-causing germline mutation(s) inTolerante
FUNÇÃO

E3 ubiquitin-protein ligase component of a retrotranslocation channel required for peroxisome organization by mediating export of the PEX5 receptor from peroxisomes to the cytosol, thereby promoting PEX5 recycling (PubMed:24662292). The retrotranslocation channel is composed of PEX2, PEX10 and PEX12; each subunit contributing transmembrane segments that coassemble into an open channel that specifically allows the passage of PEX5 through the peroxisomal membrane (By similarity). PEX10 also regula

LOCALIZAÇÃO

Peroxisome membrane

VIAS BIOLÓGICAS (2)
Peroxisomal protein importE3 ubiquitin ligases ubiquitinate target proteins
MECANISMO DE DOENÇA

Peroxisome biogenesis disorder complementation group 7

A peroxisomal disorder arising from a failure of protein import into the peroxisomal membrane or matrix. The peroxisome biogenesis disorders (PBD group) are genetically heterogeneous with at least 14 distinct genetic groups as concluded from complementation studies. Include disorders are: Zellweger syndrome (ZWS), neonatal adrenoleukodystrophy (NALD), infantile Refsum disease (IRD), and classical rhizomelic chondrodysplasia punctata (RCDP). ZWS, NALD and IRD are distinct from RCDP and constitute a clinical continuum of overlapping phenotypes known as the Zellweger spectrum (PBD-ZSS).

EXPRESSÃO TECIDUAL(Ubíquo)
Testículo
33.5 TPM
Glândula adrenal
23.3 TPM
Brain Spinal cord cervical c-1
22.1 TPM
Nervo tibial
20.8 TPM
Fibroblastos
20.1 TPM
OUTRAS DOENÇAS (5)
peroxisome biogenesis disorder 6Bperoxisome biogenesis disorder 6A (Zellweger)autosomal recessive ataxia due to PEX10 deficiencyZellweger spectrum disorders
HGNC:8851UniProt:O60683
PEX1Peroxisomal ATPase PEX1Disease-causing germline mutation(s) inTolerante
FUNÇÃO

Component of the PEX1-PEX6 AAA ATPase complex, a protein dislocase complex that mediates the ATP-dependent extraction of the PEX5 receptor from peroxisomal membranes, an essential step for PEX5 recycling (PubMed:11439091, PubMed:16314507, PubMed:16854980, PubMed:21362118, PubMed:29884772). Specifically recognizes PEX5 monoubiquitinated at 'Cys-11', and pulls it out of the peroxisome lumen through the PEX2-PEX10-PEX12 retrotranslocation channel (PubMed:29884772). Extraction by the PEX1-PEX6 AAA A

LOCALIZAÇÃO

Cytoplasm, cytosolPeroxisome membrane

VIAS BIOLÓGICAS (1)
Peroxisomal protein import
MECANISMO DE DOENÇA

Peroxisome biogenesis disorder complementation group 1

A peroxisomal disorder arising from a failure of protein import into the peroxisomal membrane or matrix. The peroxisome biogenesis disorders (PBD group) are genetically heterogeneous with at least 14 distinct genetic groups as concluded from complementation studies. Include disorders are: Zellweger syndrome (ZWS), neonatal adrenoleukodystrophy (NALD), infantile Refsum disease (IRD), and classical rhizomelic chondrodysplasia punctata (RCDP). ZWS, NALD and IRD are distinct from RCDP and constitute a clinical continuum of overlapping phenotypes known as the Zellweger spectrum (PBD-ZSS).

EXPRESSÃO TECIDUAL(Ubíquo)
Ovário
23.8 TPM
Nervo tibial
23.3 TPM
Cervix Endocervix
23.1 TPM
Tireoide
21.9 TPM
Cerebelo
21.8 TPM
OUTRAS DOENÇAS (6)
peroxisome biogenesis disorder 1Bperoxisome biogenesis disorder 1A (Zellweger)peroxisome biogenesis disorder due to PEX1 defectZellweger spectrum disorders
HGNC:8850UniProt:O43933
PEX13Peroxisomal membrane protein PEX13Disease-causing germline mutation(s) inTolerante
FUNÇÃO

Component of the PEX13-PEX14 docking complex, a translocon channel that specifically mediates the import of peroxisomal cargo proteins bound to PEX5 receptor (PubMed:28765278, PubMed:8858165, PubMed:9653144). The PEX13-PEX14 docking complex forms a large import pore which can be opened to a diameter of about 9 nm (By similarity). Mechanistically, PEX5 receptor along with cargo proteins associates with the PEX14 subunit of the PEX13-PEX14 docking complex in the cytosol, leading to the insertion o

LOCALIZAÇÃO

Peroxisome membrane

VIAS BIOLÓGICAS (3)
Peroxisomal protein importE3 ubiquitin ligases ubiquitinate target proteinsClass I peroxisomal membrane protein import
MECANISMO DE DOENÇA

Peroxisome biogenesis disorder complementation group 13

A peroxisomal disorder arising from a failure of protein import into the peroxisomal membrane or matrix. The peroxisome biogenesis disorders (PBD group) are genetically heterogeneous with at least 14 distinct genetic groups as concluded from complementation studies. Include disorders are: Zellweger syndrome (ZWS), neonatal adrenoleukodystrophy (NALD), infantile Refsum disease (IRD), and classical rhizomelic chondrodysplasia punctata (RCDP). ZWS, NALD and IRD are distinct from RCDP and constitute a clinical continuum of overlapping phenotypes known as the Zellweger spectrum (PBD-ZSS).

EXPRESSÃO TECIDUAL(Ubíquo)
Tireoide
13.9 TPM
Testículo
13.9 TPM
Fibroblastos
12.2 TPM
Vagina
11.9 TPM
Esôfago - Mucosa
11.2 TPM
OUTRAS DOENÇAS (4)
peroxisome biogenesis disorder 11A (Zellweger)peroxisome biogenesis disorder 11BZellweger spectrum disordersobsolete neonatal adrenoleukodystrophy
HGNC:8855UniProt:Q92968
PEX11BPeroxisomal membrane protein 11BDisease-causing germline mutation(s) inTolerante
FUNÇÃO

Involved in peroxisomal proliferation (PubMed:9792670). May regulate peroxisome division by recruiting the dynamin-related GTPase DNM1L to the peroxisomal membrane (PubMed:12618434). Promotes membrane protrusion and elongation on the peroxisomal surface (PubMed:20826455)

LOCALIZAÇÃO

Peroxisome membrane

VIAS BIOLÓGICAS (1)
Class I peroxisomal membrane protein import
MECANISMO DE DOENÇA

Peroxisome biogenesis disorder 14B

An autosomal recessive peroxisome biogenesis disorder characterized clinically by mild intellectual disability, congenital cataracts, progressive hearing loss, and polyneuropathy. Additionally, recurrent migraine-like episodes following mental stress or physical exertion, not a common feature in peroxisome disorders, are observed.

EXPRESSÃO TECIDUAL(Ubíquo)
Brain Frontal Cortex BA9
64.0 TPM
Cérebro - Hemisfério cerebelar
63.3 TPM
Linfócitos
57.4 TPM
Testículo
54.2 TPM
Cerebelo
51.1 TPM
OUTRAS DOENÇAS (3)
peroxisome biogenesis disorder 14Bobsolete neonatal adrenoleukodystrophyZellweger spectrum disorders
HGNC:8853UniProt:O96011
PEX26Peroxisome assembly protein 26Disease-causing germline mutation(s) inTolerante
FUNÇÃO

Peroxisomal docking factor that anchors PEX1 and PEX6 to peroxisome membranes (PubMed:12717447, PubMed:12851857, PubMed:16257970, PubMed:16763195, PubMed:16854980, PubMed:21362118). PEX26 is therefore required for the formation of the PEX1-PEX6 AAA ATPase complex, a complex that mediates the extraction of the PEX5 receptor from peroxisomal membrane (PubMed:12717447, PubMed:12851857, PubMed:16257970, PubMed:16763195, PubMed:16854980, PubMed:21362118)

LOCALIZAÇÃO

Peroxisome membrane

VIAS BIOLÓGICAS (2)
Peroxisomal protein importClass I peroxisomal membrane protein import
MECANISMO DE DOENÇA

Peroxisome biogenesis disorder complementation group 8

A peroxisomal disorder arising from a failure of protein import into the peroxisomal membrane or matrix. The peroxisome biogenesis disorders (PBD group) are genetically heterogeneous with at least 14 distinct genetic groups as concluded from complementation studies. Include disorders are: Zellweger syndrome (ZWS), neonatal adrenoleukodystrophy (NALD), infantile Refsum disease (IRD), and classical rhizomelic chondrodysplasia punctata (RCDP). ZWS, NALD and IRD are distinct from RCDP and constitute a clinical continuum of overlapping phenotypes known as the Zellweger spectrum (PBD-ZSS).

EXPRESSÃO TECIDUAL(Ubíquo)
Linfócitos
12.4 TPM
Intestino delgado
9.0 TPM
Brain Frontal Cortex BA9
9.0 TPM
Cérebro - Hemisfério cerebelar
8.8 TPM
Fibroblastos
8.2 TPM
OUTRAS DOENÇAS (4)
peroxisome biogenesis disorder 7A (Zellweger)peroxisome biogenesis disorder 7BZellweger spectrum disordersobsolete neonatal adrenoleukodystrophy
HGNC:22965UniProt:Q7Z412
PEX5Peroxisomal targeting signal 1 receptorDisease-causing germline mutation(s) inTolerante
FUNÇÃO

Receptor that mediates peroxisomal import of proteins containing a C-terminal PTS1-type tripeptide peroxisomal targeting signal (SKL-type) (PubMed:11101887, PubMed:11336669, PubMed:12456682, PubMed:16314507, PubMed:17157249, PubMed:17428317, PubMed:21976670, PubMed:26344566, PubMed:7706321, PubMed:7719337, PubMed:7790377). Binds to cargo proteins containing a PTS1 peroxisomal targeting signal in the cytosol, and translocates them into the peroxisome matrix by passing through the PEX13-PEX14 dock

LOCALIZAÇÃO

Cytoplasm, cytosolPeroxisome matrix

VIAS BIOLÓGICAS (1)
Pexophagy
MECANISMO DE DOENÇA

Peroxisome biogenesis disorder 2A

A fatal peroxisome biogenesis disorder belonging to the Zellweger disease spectrum and characterized clinically by severe neurologic dysfunction with profound psychomotor retardation, severe hypotonia and neonatal seizures, craniofacial abnormalities, liver dysfunction, and biochemically by the absence of peroxisomes. Additional features include cardiovascular and skeletal defects, renal cysts, ocular abnormalities, and hearing impairment. Most severely affected individuals with the classic form of the disease (classic Zellweger syndrome) die within the first year of life.

EXPRESSÃO TECIDUAL(Ubíquo)
Testículo
77.7 TPM
Cerebelo
49.0 TPM
Cérebro - Hemisfério cerebelar
48.3 TPM
Pituitária
46.8 TPM
Nervo tibial
44.2 TPM
OUTRAS DOENÇAS (5)
peroxisome biogenesis disorder 2Brhizomelic chondrodysplasia punctata type 5peroxisome biogenesis disorder 2A (Zellweger)Zellweger spectrum disorders
HGNC:9719UniProt:P50542

Variantes genéticas (ClinVar)

392 variantes patogênicas registradas no ClinVar.

🧬 PEX16: NM_004813.4(PEX16):c.140dup (p.Glu48fs) ()
🧬 PEX16: NM_004813.4(PEX16):c.359+2T>G ()
🧬 PEX16: NM_004813.4(PEX16):c.51_52del (p.His18fs) ()
🧬 PEX16: NM_004813.4(PEX16):c.823del (p.Arg275fs) ()
🧬 PEX16: NM_004813.4(PEX16):c.254G>A (p.Trp85Ter) ()
Ver todas no ClinVar

Diagnóstico

Os sinais que médicos procuram e os exames que confirmam

Carregando...

Tratamento e manejo

Remédios, cuidados de apoio e o que precisa acompanhar

Pipeline de tratamentos
Pipeline regulatório — de medicamentos já aprovados a drogas em pesquisa exploratória.
3Fase 31
2Fase 22
·Pré-clínico3
Medicamentos catalogadosEnsaios clínicos· 0 medicamentos · 6 ensaios
Carregando informações de tratamento...

Onde tratar no SUS

Hospitais de referência no Brasil e o protocolo oficial do SUS (PCDT)

🇧🇷 Atendimento SUS — Síndrome Zellweger

🗺️

Selecione um estado ou use sua localização para ver resultados.

Dados de DATASUS/CNES, SBGM, ABNeuro e Ministério da Saúde. Sempre confirme a disponibilidade diretamente com o estabelecimento.

Pesquisa ativa

Ensaios clínicos abertos e novidades científicas recentes

🟢 Recrutando agora

1 pesquisa recrutando participantes. Converse com seu médico sobre a possibilidade de participar.

Outros ensaios clínicos

11 ensaios clínicos encontrados, 2 ativos.

Distribuição por fase
Ver todos no ClinicalTrials.gov
🧪 Está conduzindo uma pesquisa?
Divulgue para pacientes e familiares que acompanham esta doença.
Divulgar pesquisa →

Publicações mais relevantes

🥇Melhor nível de evidência: Revisão sistemática
Timeline de publicações
129 papers (10 anos)
#1

Dysregulated lipid metabolism and hypomyelination in postnatal peroxisome-deficient Pex2 knockout Zellweger mice.

Frontiers in molecular neuroscience2026

Peroxisomes are dynamic organelles that play a crucial role in cellular metabolism, particularly in fatty acid degradation, cholesterol homeostasis and reactive oxygen species metabolism. Their dysfunction is associated with severe neurological disorders, including Zellweger spectrum disorders (ZSD) and X-linked adrenoleukodystrophy (X-ALD). In this study, we investigated the relationship between cholesterol homeostasis and myelination in postnatal peroxisome-deficient Pex2 knockout mice. We dissected the central nervous system (CNS) of 10-day-old (P10) control and Pex2 -/- mice into five regions: spinal cord, brainstem, cerebellum, diencephalon and cerebral cortex. Catalase activity, a marker enzyme of peroxisomes, was significantly increased in CNS regions of Pex2 -/- mice, indicating an oxidative imbalance. Proteomic analysis revealed significant alterations in peroxisomal proteins and pathways related to neurodegenerative diseases, cholesterol and fatty acid metabolism and mRNA processing. Cholesterol biosynthesis was particularly dysregulated: enzyme activities, mRNA, and protein levels were reduced in white matter regions but increased in the cerebral cortex. The elevated desmosterol levels in the brain of Pex2 -/- mice indicate impaired cholesterol synthesis. Sphingolipid metabolism was also altered in the peroxisome-deficient CNS, as the protein levels of enzymes dihydroceramide desaturase 1, ceramide synthase 2, fatty acid 2-hydroxylase, and UDP-glycosyltransferase 8 were significantly decreased. Myelination was significantly reduced throughout the CNS, as evidenced by decreased activities of the myelin marker 2',3'-cyclic nucleotide 3'-phosphodiesterase (CNP) and decreased mRNA and protein levels of myelin-associated proteins. The consistent decrease in ribosomal protein S6 phosphorylation in the CNS of Pex2 -/- mice suggests that decreased mechanistic target of rapamycin complex 1 (mTORC1) activity contributes to hypomyelination. Gene expression analysis revealed an upregulation of pro-inflammatory cytokines and altered expression of some homeostatic and disease-associated microglial (DAM) genes. However, full DAM activation was not yet observed in Pex2 -/- mice at P10. In conclusion, this study shows that systemic peroxisome deficiency leads to severe hypomyelination and dysregulation of cholesterol and fatty acid metabolism in the CNS, providing new insights into the pathophysiology of peroxisomal disorders.

#2

Identification of Potential Therapeutic Agents for Primary Amebic Meningoencephalitis Using Text Mining and Bioinformatics Analyses.

Analytical cellular pathology (Amsterdam)2026

Naegleria fowleri, the brain-eating ameba, causes primary amebic meningoencephalitis (PAM), a fatal infectious disease that affects the central nervous system (CNS). We aimed to evaluate the functions and potential drugs targeting PAM using text mining and bioinformatics analyses. PAM-associated genes were identified using a disease database and mined from literature. To identify candidate drugs targeting PAM, 218 genes were analyzed using PanDrugs, drug Manually Annotated Targets and Drugs Online Resource (MATADOR), and the drug Comparative Toxicogenomics Database (CTD) by text mining. Kyoto Encyclopedia of Genes and Genomes (KEGG) and Gene Ontology (GO) functional analyses were performed to examine the mechanism of action of PAM. The GO functions of genes involved in PAM identified by text mining were leukocyte differentiation and the regulation of cytokine production. Disease-related PAM analyses indicated association with Zellweger syndrome, peroxisomal disease, periodontitis, and leishmaniasis. KEGG enrichment included pathways related to inflammatory bowel disease, malaria, interleukin (IL)-17 signaling pathway, Yersinia infection, Chagas disease, amebiasis, rheumatoid arthritis, pathogenic Escherichia coli infection, lipids, atherosclerosis, and peroxisomes. In addition, arsenic trioxide, bortezomib, dasatinib, bosutinib, bevacizumab, paclitaxel, midostaurin, tamoxifen, copanlisib, and pazopanib were identified as potential drugs targeting PAM using PanDrugs software. Our analyses revealed that text mining-related PAM genes were enriched in several pathways, such as peroxisomes and protein localization. We suggest that PAM is linked to other diseases, such as Zellweger's syndrome, leishmaniasis, and periodontitis, and provide potential drugs for effective treatment.

#3

Identification of a new frameshift homozygous variant of PEX3 gene in a preterm infant with profound global developmental delay and bilateral ptosis: a case report and updated literature review.

BMC pediatrics2026 Jan 06

Loss-of-function mutations in PEX3 have been associated with Zellweger syndrome (ZS), a severe form of peroxisome biogenesis disorder (PBD) characterized by significant global developmental delay, muscle weakness with bilateral ptosis, cholestasis, hypotonia, and seizures. ZS can be life-threatening if manifested in the neonatal period. This study presents a unique case of a male infant with severe ZS whose condition deteriorated despite intensive supportive treatment. Through whole-exome sequencing, an intronic variant NM_003630.2:c.288-10T > A, located 10 nucleotides before exon 4 of the PEX3 gene, was identified. Sanger sequencing revealed a homozygous variant in the infant and a heterozygous variant in both parents. Further analysis confirmed the abnormal transcript of the PEX3 gene caused by a frameshift variant resulting from the PEX3 gene c.288-10T > A mutation. This modification led to a splicing error that deleted exon 4, causing a direct splicing of exons 3 and 5. This alteration produced a truncated protein comprising 32 incorrect amino acids. We systematically summarized common phenotypes across 10 reported PEX3-related Zellweger spectrum disorder (ZSD) cases (including the current patient): profound global developmental delay (9/10), bilateral ptosis/ocular motility dysfunction (7/10), and hypotonia (7/10). These consistent phenotypes reflect genotype-phenotype correlation in PEX3-related ZSD, providing valuable clues for early clinical suspicion and diagnosis. We report the first Chinese case of severe ZSD caused by the PEX3 variant [c.288-10T > A: p.P97Ffs*33], broadening the spectrum of severe ZSDs associated with pathogenic PEX3 variants. Our summary of 10 PEX3-related ZSD cases identifies three core phenotypes—profound global developmental delay, bilateral ptosis, and hypotonia—that aid early clinical suspicion and targeted genetic testing. The online version contains supplementary material available at 10.1186/s12887-025-06472-0.

#4

What Peroxisomes (Don't) do to Mitochondria.

Contact (Thousand Oaks (Ventura County, Calif.))2026

Mitochondria and peroxisomes have long been recognized as interconnected. More than half a century ago it was observed that both types of cell organelles exhibit defects in peroxisome biogenesis disorders. Remarkably, until today, the molecular basis of this connection remains elusive. This Short Review aims to highlight some of the functional links between peroxisomes and mitochondria, and how genetic defects in peroxisomes may impact mitochondria.

#5

New multiplex LC-MS/MS method for lipid biomarker analysis of inherited neurodegenerative metabolic diseases.

Journal of lipid research2026 Jan

A significant number of inherited neurodegenerative metabolic diseases (NMDs) arise from altered lipid metabolism, including impaired degradation of sphingolipids and dysfunction in organelle-related machineries involved in lipid processing and trafficking. These lipid dysregulations profoundly impact cellular membranes, signaling pathways, and myelin integrity, contributing to the complex and multisystemic clinical phenotypes characteristic of NMD, which often complicate diagnosis and delay treatment initiation. Here, we present a high-throughput, multiplex LC-MS/MS method for the analysis of an extended panel of NMD biomarkers in plasma and dried blood spots. One-step sample extraction and targeted LC-MS/MS acquisitions in positive and negative ionization allowed the simultaneous measurement of 13 diagnostic biomarkers associated with GM1 and GM2 gangliosidosis, Fabry, Gaucher, and Krabbe diseases, acid sphingomyelinase deficiency, Niemann-Pick disease type C, X-linked adrenoleukodystrophy, peroxisomal biogenesis disorders (Zellweger syndrome), metachromatic leukodystrophy, and mental retardation, enteropathy, deafness, neuropathy, ichthyosis, keratoderma (MEDNIK)/MEDNIK-like syndromes, a disorder of cellular trafficking. The method was analytically and clinically validated, confirming the diagnosis of all targeted NMDs in samples from 89 patients. Additionally, the method allowed the differentiation of X-linked adrenoleukodystrophy from peroxisomal biogenesis disorder and revealed the elevation of C18- and C16-sulfatides in Krabbe disease and MEDNIK syndrome, respectively. This multiplex assay enhances diagnostic efficiency and expands the discovery of novel biomarkers, enabling the quantification of diagnostic markers for a wide range of NMDs. The method is suitable for diagnosis of NMD, as a first- or second-tier test in neonatal screening, as confirmatory testing of variant of unknown significance in genetic panels and for longitudinal monitoring in treatable diseases.

Publicações recentes

Ver todas no PubMed

📚 EuropePMC333 artigos no totalmostrando 195

2026

Dysregulated lipid metabolism and hypomyelination in postnatal peroxisome-deficient Pex2 knockout Zellweger mice.

Frontiers in molecular neuroscience
2026

Identification of Potential Therapeutic Agents for Primary Amebic Meningoencephalitis Using Text Mining and Bioinformatics Analyses.

Analytical cellular pathology (Amsterdam)
2026

What Peroxisomes (Don't) do to Mitochondria.

Contact (Thousand Oaks (Ventura County, Calif.))
2026

Identification of a new frameshift homozygous variant of PEX3 gene in a preterm infant with profound global developmental delay and bilateral ptosis: a case report and updated literature review.

BMC pediatrics
2026

New multiplex LC-MS/MS method for lipid biomarker analysis of inherited neurodegenerative metabolic diseases.

Journal of lipid research
2026

Late diagnosis of Heimler syndrome and review of the genetic and phenotypic spectrum.

Ophthalmic genetics
2025

Early diagnosis of Zellweger syndrome through a Nationwide Liver Disease Registry System (CIRCLe).

Pediatrics international : official journal of the Japan Pediatric Society
2025

Detection of a Novel Homozygous PEX5 Stop-Loss Variant Associated with Zellweger Syndrome in a Highly Endogamic Family.

The application of clinical genetics
2025

Urine organic acid analysis as a tool in evaluation for Zellweger Spectrum disorder: A retrospective study.

Molecular genetics and metabolism
2025

Molecular mechanism of substrate transport by human peroxisomal ABCD3.

bioRxiv : the preprint server for biology
2025

Drosophila models uncover substrate channeling effects on phospholipids and sphingolipids in peroxisomal biogenesis disorders.

PloS one
2025

Comparison of Caregiver-Reported Dietary Intake Methods in Zellweger Spectrum Disorder.

Nutrients
2025

Spectrum of genetic alterations in patients with peroxisome biogenesis defects in the Iranian population: a case series study.

BMC medical genomics
2025

Effectiveness and Safety of High-Dose Oral Phenobarbital in Children With Recurrent and Treatment-Refractory Seizures.

Clinical pediatrics
2025

Using multiple modalities to confirm diagnosis in patients with suspected peroxisome biogenesis disorders.

Molecular genetics and metabolism
2025

Spatial characterization of RPE structure and lipids in the PEX1-p.Gly844Asp mouse model for Zellweger spectrum disorder.

Journal of lipid research
2025

Cholesterol ensures ciliary polycystin-2 localization to prevent polycystic kidney disease.

Life science alliance
2025

Zellweger spectrum disorder presenting with opsoclonus-myoclonus-ataxia syndrome: a case report on immunotherapy.

Acta neurologica Belgica
2025

Zellweger syndrome; identification of mutations in PEX19 and PEX26 gene in Saudi families.

Annals of medicine
2024

Peroxisomal dysfunction interferes with odontogenesis and leads to developmentally delayed teeth and defects in distinct dental cells in Pex11b-deficient mice.

PloS one
2025

Subacute Neuropathy Post-Liver Transplantation in Zellweger Spectrum Disorder: A Case Report.

American journal of medical genetics. Part A
2024

Normal very long-chain fatty acids level in a patient with peroxisome biogenesis disorders: a case report.

BMC pediatrics
2024

Biallelic Deletion of PEX26 Exon 4 in a Boy with Phenotypic Features of both Zellweger Syndrome and Infantile Refsum Disease.

Molecular syndromology
2024

Newborn Screening for X-Linked Adrenoleukodystrophy (X-ALD): Biochemical, Molecular, and Clinical Characteristics of Other Genetic Conditions.

Genes
2024

A novel splice variant in intron 10 of PEX6 is associated with Zellweger Syndrome in a Chinese neonate.

Gene
2024

Pigmentary retinal dystrophy associated with peroxisome biogenesis disorder-Zellweger syndrome spectrum.

Oxford medical case reports
2024

Mixed coagulopathy in patient with peroxisomal disorder, Zellweger syndrome.

Pediatric blood &amp; cancer
2024

Systematic study of ophthalmological findings in 10 patients with PEX1-mediated Zellweger spectrum disorder.

Ophthalmic genetics
2024

[A case of Zellweger syndrome caused by PEX13 gene variation].

Zhonghua er ke za zhi = Chinese journal of pediatrics
2024

Safety and tolerance of the ketogenic diet in patients with Zellweger Syndrome.

Epilepsy &amp; behavior reports
2024

Zellweger Syndrome: A Case Report.

JNMA; journal of the Nepal Medical Association
2024

Peroxisome deficiency underlies failures in hepatic immune cell development and antigen presentation in a severe Zellweger disease model.

Cell reports
2024

Plasma C24:0- and C26:0-lysophosphatidylcholines are reliable biomarkers for the diagnosis of peroxisomal β-oxidation disorders.

Journal of lipid research
2024

The Pathophysiology of Inherited Renal Cystic Diseases.

Genes
2024

[Zellweger syndrome caused by PEX6 gene variation in 2 cases and literature review].

Zhonghua er ke za zhi = Chinese journal of pediatrics
2024

Liver Transplantation for Zellweger Syndrome.

Indian journal of pediatrics
2023

The subset of peroxisomal tail-anchored proteins do not reach peroxisomes via ER, instead mitochondria can be involved.

PloS one
2023

Abnormal activation of MAPKs pathways and inhibition of autophagy in a group of patients with Zellweger spectrum disorders and X-linked adrenoleukodystrophy.

Orphanet journal of rare diseases
2024

Severe Zellweger spectrum disorder due to a novel missense variant in the PEX13 gene: A case report and the literature review.

Molecular genetics &amp; genomic medicine
2023

World-Renowned "Swiss" Pediatricians, Their Syndromes, and Matching Imaging Findings: A Historical Perspective.

Children (Basel, Switzerland)
2023

Zellweger's Syndrome With PEX6 Gene Mutation in Mixteco Neonates Due to Possible Founder Effect.

Cureus
2023

Dried blood spot-based newborn screening for bile acid synthesis disorders, Zellweger spectrum disorder, and Niemann-Pick type C1 by detection of bile acid metabolites.

Molecular genetics and metabolism
2023

A new test method for biochemical analysis of plasmalogens in dried blood spots and erythrocytes from patients with peroxisomal disorders.

Journal of inherited metabolic disease
2023

Zellweger Spectrum Disorder: Ophthalmic Findings from a New Natural History Study Cohort and Scoping Literature Review.

Ophthalmology
2023

Autosomal dominant Zellweger spectrum disorder caused by de novo variants in PEX14 gene.

Genetics in medicine : official journal of the American College of Medical Genetics
2023

Novel PEX1 mutations in fibroblasts from children with Zellweger spectrum disorders exhibit temperature sensitive characteristics.

Epilepsy &amp; behavior : E&amp;B
2023

Uncombable Hair in a Case of Zellweger Syndrome - A New Association.

Indian dermatology online journal
2023

A Case Study Through an Audiological Perspective on a Pediatric Patient Diagnosed with Zellweger Syndrome.

Indian journal of otolaryngology and head and neck surgery : official publication of the Association of Otolaryngologists of India
2023

Multivariate analysis and model building for classifying patients in the peroxisomal disorders X-linked adrenoleukodystrophy and Zellweger syndrome in Chinese pediatric patients.

Orphanet journal of rare diseases
2023

A homozygous Gly470Ala variant in PEX6 causes severe Zellweger spectrum disorder.

American journal of medical genetics. Part A
2023

The origin of long-chain fatty acids required for de novo ether lipid/plasmalogen synthesis.

Journal of lipid research
2023

Novel mutation causing Zellweger syndrome.

BMJ case reports
2022

Loss of Pex1 in Inner Ear Hair Cells Contributes to Cochlear Synaptopathy and Hearing Loss.

Cells
2023

Development of a system adapted for the diagnosis and evaluation of peroxisomal disorders by measuring bile acid intermediates.

Brain &amp; development
2022

Diagnostic Odyssey in an Adult Patient with Ophthalmologic Abnormalities and Hearing Loss: Contribution of RNA-Seq to the Diagnosis of a PEX1 Deficiency.

International journal of molecular sciences
2022

[A case of mild Zellweger spectrum disorder first diagnosed as Usher syndrome].

[Zhonghua yan ke za zhi] Chinese journal of ophthalmology
2022

Control of mitochondrial dynamics and apoptotic pathways by peroxisomes.

Frontiers in cell and developmental biology
2022

High incidence of null variants identified from newborn screening of X-linked adrenoleukodystrophy in Taiwan.

Molecular genetics and metabolism reports
2022

Hypomorphic mutation of PEX3 with peroxisomal mosaicism reveals the oscillating nature of peroxisome biogenesis coupled with differential metabolic activities.

Molecular genetics and metabolism
2022

Genotype-phenotype correlations and disease mechanisms in PEX13-related Zellweger spectrum disorders.

Orphanet journal of rare diseases
2022

Insights into the Structure and Function of the Pex1/Pex6 AAA-ATPase in Peroxisome Homeostasis.

Cells
2022

Characterization of Severity in Zellweger Spectrum Disorder by Clinical Findings: A Scoping Review, Meta-Analysis and Medical Chart Review.

Cells
2022

Case Report: Zellweger Syndrome and Humoral Immunodeficiency: The Relevance of Newborn Screening for Primary Immunodeficiency.

Frontiers in pediatrics
2022

Early Neuroimaging in Zellweger Spectrum Disorders.

Neurology India
2022

Clinical, neuroradiological, and molecular characterization of patients with atypical Zellweger spectrum disorder caused by PEX16 mutations: a case series.

Neurogenetics
2021

An Infant with Blended Phenotype of Zellweger Spectrum Disorder and Congenital Muscular Dystrophy.

Annals of Indian Academy of Neurology
2021

Quantitative Proteomics and Differential Protein Abundance Analysis after the Depletion of PEX3 from Human Cells Identifies Additional Aspects of Protein Targeting to the ER.

International journal of molecular sciences
2021

Prenatal diagnosis of zellweger syndrome by fetal MRI: a case report.

Radiology case reports
2021

Very long chain acylcarnitines and lysophosphatidylcholines in screening of peroxisomal disease in children by tandem mass spectrometry.

Zhejiang da xue xue bao. Yi xue ban = Journal of Zhejiang University. Medical sciences
2021

IMPAIRMENT OF PEROXISOME BIOGENESIS IN THE SPECTRUM OF ZELLWEGER SYNDROME (CLINICAL CASE).

Georgian medical news
2021

Diagnostic challenges and disease management in patients with a mild Zellweger spectrum disorder phenotype.

Molecular genetics and metabolism
2022

A Retrospective Study of Hearing Loss in Patients Diagnosed with Peroxisome Biogenesis Disorders in the Zellweger Spectrum.

Ear and hearing
2021

Cholbam® and Zellweger spectrum disorders: treatment implementation and management.

Orphanet journal of rare diseases
2021

The Nitric Oxide Donor, S-Nitrosoglutathione, Rescues Peroxisome Number and Activity Defects in PEX1G843D Mild Zellweger Syndrome Fibroblasts.

Frontiers in cell and developmental biology
2021

PEX26 gene genotype-phenotype correlation in neonates with Zellweger syndrome.

Translational pediatrics
2021

Mitochondria as emergency landing for abandoned peroxins.

EMBO reports
2021

The biochemical basis of mitochondrial dysfunction in Zellweger Spectrum Disorder.

EMBO reports
2021

LC-MS Based Platform Simplifies Access to Metabolomics for Peroxisomal Disorders.

Metabolites
2021

Zebrafish model of human Zellweger syndrome reveals organ-specific accumulation of distinct fatty acid species and widespread gene expression changes.

Molecular genetics and metabolism
2021

Compound heterozygous p. Arg949Trp and p. Gly970Ala mutations deteriorated the function of PEX1p: A study on PEX1 in a patient with Zellweger syndrome.

Journal of cellular biochemistry
2021

A novel mutation in the PEX26 gene in a family from Dagestan with members affected by Zellweger spectrum disorder.

Molecular genetics and metabolism reports
2021

A Chinese newborn with Zellweger syndrome and compound heterozygous mutations novel in the PEX1 gene: a case report and literature review.

Translational pediatrics
2020

Pipecolic Acid Quantification Using Gas Chromatography-coupled Mass Spectrometry.

Bio-protocol
2021

Depletion of HNRNPA1 induces peroxisomal autophagy by regulating PEX1 expression.

Biochemical and biophysical research communications
2021

Diagnosis and Management of Renal Cystic Disease of the Newborn: Core Curriculum 2021.

American journal of kidney diseases : the official journal of the National Kidney Foundation
2020

Zellweger Syndrome Disorders: From Severe Neonatal Disease to Atypical Adult Presentation.

Advances in experimental medicine and biology
2020

Peroxisomal Dysfunction and Oxidative Stress in Neurodegenerative Disease: A Bidirectional Crosstalk.

Advances in experimental medicine and biology
2021

Expanded Carrier Screening and the Complexity of Implementation.

Obstetrics and gynecology
2020

High Dose Versus Low Dose Syngeneic Hepatocyte Transplantation in Pex1-G844D NMRI Mouse Model is Safe but Does Not Achieve Long Term Engraftment.

Cells
2020

Functional Peroxisomes Are Essential for Efficient Cholesterol Sensing and Synthesis.

Frontiers in cell and developmental biology
2020

Overwhelming sepsis in a neonate affected by Zellweger syndrome due to a compound heterozygosis in PEX 6 gene: a case report.

BMC medical genetics
2021

A founder mutation in PEX12 among Egyptian patients in peroxisomal biogenesis disorder.

Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology
2020

Genome sequencing identifies a rare case of moderate Zellweger spectrum disorder caused by a PEX3 defect: Case report and literature review.

Molecular genetics and metabolism reports
2020

First Case of Peroxisomal D-bifunctional Protein Deficiency with Novel HSD17B4 Mutations and Progressive Neuropathy in Korea.

Journal of Korean medical science
2020

Serum very long-chain fatty acids (VLCFA) levels as predictive biomarkers of diseases severity and probability of survival in peroxisomal disorders.

PloS one
2020

Peroxisome-Deficiency and HIF-2α Signaling Are Negative Regulators of Ketohexokinase Expression.

Frontiers in cell and developmental biology
2020

Longitudinal study of Pex1-G844D NMRI mouse model: A robust pre-clinical model for mild Zellweger spectrum disorder.

Biochimica et biophysica acta. Molecular basis of disease
2020

Mild form of Zellweger Spectrum Disorders (ZSD) due to variants in PEX1: Detailed clinical investigation in a 9-years-old female.

Molecular genetics and metabolism reports
2020

Recent insights into peroxisome biogenesis and associated diseases.

Journal of cell science
2020

Insufficiency of ciliary cholesterol in hereditary Zellweger syndrome.

The EMBO journal
2020

Blenderized Tube Feeding: Health Outcomes and Review of Homemade and Commercially Prepared Products.

Nutrition in clinical practice : official publication of the American Society for Parenteral and Enteral Nutrition
2020

Exome sequencing identifies PEX6 mutations in three cases diagnosed with Retinitis Pigmentosa and hearing impairment.

Molecular vision
2020

Accurate and live peroxisome biogenesis evaluation achieved by lentiviral expression of a green fluorescent protein fused to a peroxisome targeting signal 1.

Histochemistry and cell biology
2020

Two different missense mutations of PEX genes in two similar patients with severe Zellweger syndrome: an argument on the genotype-phenotype correlation.

Journal of pediatric endocrinology &amp; metabolism : JPEM
2020

Open-label Phase 3 Continuation Study of Cholic Acid in Patients With Inborn Errors of Bile Acid Synthesis.

Journal of pediatric gastroenterology and nutrition
2019

Neonate with classic Zellweger syndrome.

International journal of pediatrics &amp; adolescent medicine
2019

Genetic Deciphering of Early-Onset and Severe Retinal Dystrophy Associated with Sensorineural Hearing Loss.

Advances in experimental medicine and biology
2020

A Genetic Screen for Genes That Impact Peroxisomes in Drosophila Identifies Candidate Genes for Human Disease.

G3 (Bethesda, Md.)
2020

Mild Zellweger syndrome due to functionally confirmed novel PEX1 variants.

Journal of applied genetics
2019

Structural Mapping of Missense Mutations in the Pex1/Pex6 Complex.

International journal of molecular sciences
2019

A longitudinal study of retinopathy in the PEX1-Gly844Asp mouse model for mild Zellweger Spectrum Disorder.

Experimental eye research
2019

Chinese patients with adrenoleukodystrophy and Zellweger spectrum disorder presenting with hereditary spastic paraplegia.

Parkinsonism &amp; related disorders
2019

Liver disease predominates in a mouse model for mild human Zellweger spectrum disorder.

Biochimica et biophysica acta. Molecular basis of disease
2019

Hepatic symptoms and histology in 13 patients with a Zellweger spectrum disorder.

Journal of inherited metabolic disease
2019

Correspondence Reply to Kitaoka et al.

Pediatric neurology
2019

Chondrodisplasia Punctata of Hip Joints on Routine Radiography Provided a Diagnostic Clue of Zellweger Syndrome.

Pediatric neurology
2019

Chondrodysplasia Punctata: A Clue to the Zellweger Spectrum Disorders.

Pediatric neurology
2019

Inherited metabolic disorders presenting as hypoxic ischaemic encephalopathy: A case series of patients presenting at a tertiary care hospital in Pakistan.

JPMA. The Journal of the Pakistan Medical Association
2019

Carrier frequency estimation of Zellweger spectrum disorder using ExAC database and bioinformatics tools.

Genetics in medicine : official journal of the American College of Medical Genetics
2019

The cholic acid extension study in Zellweger spectrum disorders: Results and implications for therapy.

Journal of inherited metabolic disease
2019

Metabolic liver diseases presenting with neonatal cholestasis: at the crossroad between old and new paradigms.

European journal of pediatrics
2019

Differential distribution of peroxisomal proteins points to specific roles of peroxisomes in the murine retina.

Molecular and cellular biochemistry
2019

The many faces of peroxisomal disorders: Lessons from a large Arab cohort.

Clinical genetics
2019

A newly identified mutation in the PEX26 gene is associated with a milder form of Zellweger spectrum disorder.

Cold Spring Harbor molecular case studies
2019

Isoform-specific domain organization determines conformation and function of the peroxisomal biogenesis factor PEX26.

Biochimica et biophysica acta. Molecular cell research
2019

Zellweger spectrum disorder patient-derived fibroblasts with the PEX1-Gly843Asp allele recover peroxisome functions in response to flavonoids.

Journal of cellular biochemistry
2018

Neonatal punctate calcifications associated with maternal mixed connective tissue disorder (MCTD).

BMJ case reports
2019

Application of machine learning algorithms for the differential diagnosis of peroxisomal disorders.

Journal of biochemistry
2018

[The importance of semiology and biochemistry in the diagnostic management of a peroxisomal biogenesis disorder].

Revista de neurologia
2018

A clinical case of Zellweger syndrome in a patient with a previous history of ocular medulloepithelioma.

Saudi journal of ophthalmology : official journal of the Saudi Ophthalmological Society
2018

Ethical considerations about changing parental attitude towards end-of-life care in twins with lethal disease.

Sudanese journal of paediatrics
2018

Expanding the spectrum of PEX16 mutations and novel insights into disease mechanisms.

Molecular genetics and metabolism reports
2019

Atypical PEX16 peroxisome biogenesis disorder with mild biochemical disruptions and long survival.

Brain &amp; development
2018

Induction of peroxisomal changes in oligodendrocytes treated with 7-ketocholesterol: Attenuation by α-tocopherol.

Biochimie
2018

Super-resolution imaging reveals the sub-diffraction phenotype of Zellweger Syndrome ghosts and wild-type peroxisomes.

Scientific reports
2018

Renal oxalate stones in children with Zellweger spectrum disorders.

Saudi journal of anaesthesia
2018

PEX5 regulates autophagy via the mTORC1-TFEB axis during starvation.

Experimental &amp; molecular medicine
2018

Brain MRI in a newborn with Zellweger syndrome: ADC quantitation in white matter disease.

Child's nervous system : ChNS : official journal of the International Society for Pediatric Neurosurgery
2018

Histologic and ultrastructural features in early and advanced phases of Zellweger spectrum disorder (infantile Refsum disease).

Ultrastructural pathology
2018

Living-donor liver transplantation for mild Zellweger spectrum disorder: Up to 17 years follow-up.

Pediatric transplantation
2018

Lipidomic Analysis: From Archaea to Mammals.

Lipids
2018

Peroxisomal disorders: Improved laboratory diagnosis, new defects and the complicated route to treatment.

Molecular and cellular probes
2018

A metabolomic map of Zellweger spectrum disorders reveals novel disease biomarkers.

Genetics in medicine : official journal of the American College of Medical Genetics
2018

Scimitar-like ossification of patellae led to diagnosis of Zellweger syndrome in newborn: a case report.

Clinical imaging
2018

Pexophagy: Molecular Mechanisms and Implications for Health and Diseases.

Molecules and cells
2018

Stippled Chondral Calcifications of the Patella in Zellweger Syndrome.

The Journal of pediatrics
2017

Allelic Expression Imbalance Promoting a Mutant PEX6 Allele Causes Zellweger Spectrum Disorder.

American journal of human genetics
2018

Impaired neurogenesis and associated gliosis in mouse brain with PEX13 deficiency.

Molecular and cellular neurosciences
2018

Coagulopathy in Zellweger spectrum disorders: a role for vitamin K.

Journal of inherited metabolic disease
2017

Mild Zellweger syndrome due to a novel PEX6 mutation: correlation between clinical phenotype and in silico prediction of variant pathogenicity.

Journal of applied genetics
2018

Oral Cholic Acid Is Efficacious and Well Tolerated in Patients With Bile Acid Synthesis and Zellweger Spectrum Disorders.

Journal of pediatric gastroenterology and nutrition
2018

Oral Cholic Acid in Zellweger Spectrum Disorders: A Word of Caution.

Journal of pediatric gastroenterology and nutrition
2018

Development and validation of a severity scoring system for Zellweger spectrum disorders.

Clinical genetics
2017

Novel PEX26 Mutation Causing Zellweger Syndrome Presenting as Feeding Intolerance and Hypotonia.

Pediatric neurology
2017

Identification of a novel mutation in PEX10 in a patient with attenuated Zellweger spectrum disorder: a case report.

Journal of medical case reports
2017

Evaluation of C26:0-lysophosphatidylcholine and C26:0-carnitine as diagnostic markers for Zellweger spectrum disorders.

Journal of inherited metabolic disease
2017

Biochemical and genetic characterization of an unusual mild PEX3-related Zellweger spectrum disorder.

Molecular genetics and metabolism
2018

Mitochondrial adventures at the organelle society.

Biochemical and biophysical research communications
2017

Zellweger syndrome: Depiction of MRI findings in early infancy at 3.0 Tesla.

The neuroradiology journal
2017

Novel compound heterozygous mutations in the PEX1 gene in two Chinese newborns with Zellweger syndrome based on whole exome sequencing.

Clinica chimica acta; international journal of clinical chemistry
2017

Clinical and Laboratory Diagnosis of Peroxisomal Disorders.

Methods in molecular biology (Clifton, N.J.)
2017

Generation of Peroxisome-Deficient Somatic Animal Cell Mutants.

Methods in molecular biology (Clifton, N.J.)
2017

Biochemical and clinical profiles of 52 Tunisian patients affected by Zellweger syndrome.

Pediatrics and neonatology
2017

Bile acid analysis in human disorders of bile acid biosynthesis.

Molecular aspects of medicine
2017

Ataxic form of autosomal recessive PEX10-related peroxisome biogenesis disorders with a novel compound heterozygous gene mutation and characteristic clinical phenotype.

Journal of the neurological sciences
2017

Allosteric modulation of peroxisomal membrane protein recognition by farnesylation of the peroxisomal import receptor PEX19.

Nature communications
2017

Newly born peroxisomes are a hybrid of mitochondrial and ER-derived pre-peroxisomes.

Nature
2017

Detection of unusual very-long-chain fatty acid and ether lipid derivatives in the fibroblasts and plasma of patients with peroxisomal diseases using liquid chromatography-mass spectrometry.

Molecular genetics and metabolism
2016

Peroxisome biogenesis and human peroxisome-deficiency disorders.

Proceedings of the Japan Academy. Series B, Physical and biological sciences
2017

DISCOVERY OF FUNCTIONAL AND DISEASE PATHWAYS BY COMMUNITY DETECTION IN PROTEIN-PROTEIN INTERACTION NETWORKS.

Pacific Symposium on Biocomputing. Pacific Symposium on Biocomputing
2016

Diagnosis of a mild peroxisomal phenotype with next-generation sequencing.

Molecular genetics and metabolism reports
2017

Peroxisomal protein PEX13 functions in selective autophagy.

EMBO reports
2016

Mitochondrial changes and oxidative stress in a mouse model of Zellweger syndrome neuropathogenesis.

Neuroscience
2016

The use of targeted genomic capture and massively parallel sequencing in diagnosis of Chinese Leukoencephalopathies.

Scientific reports
2016

Diagnostic and prognostic value of in vivo proton MR spectroscopy for Zellweger syndrome spectrum patients.

Journal of inherited metabolic disease
2016

Cholic acid therapy in Zellweger spectrum disorders.

Journal of inherited metabolic disease
2016

Prenatal observation of nystagmus, cataracts, and brain abnormalities in a case of Zellweger spectrum disorder syndrome.

Prenatal diagnosis
2016

A novel method for determining peroxisomal fatty acid β-oxidation.

Journal of inherited metabolic disease
2016

Spectrum of PEX1 and PEX6 variants in Heimler syndrome.

European journal of human genetics : EJHG
2016

Lipidomic analysis of fibroblasts from Zellweger spectrum disorder patients identifies disease-specific phospholipid ratios.

Journal of lipid research
2016

Zellweger syndrome with severe malnutrition, immunocompromised state and opportunistic infections.

BMJ case reports
2016

Clinical and Biochemical Pitfalls in the Diagnosis of Peroxisomal Disorders.

Neuropediatrics
2016

Sterol Carrier Protein-2, a Nonspecific Lipid-Transfer Protein, in Intracellular Cholesterol Trafficking in Testicular Leydig Cells.

PloS one
2016

Eye movement abnormalities in a patient with Zellweger spectrum disorder.

Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology
2016

Peroxisome biogenesis disorders in the Zellweger spectrum: An overview of current diagnosis, clinical manifestations, and treatment guidelines.

Molecular genetics and metabolism
2016

Absence of biochemical evidence at an early age delays diagnosis in a patient with a clinically severe peroxisomal biogenesis disorder.

European journal of paediatric neurology : EJPN : official journal of the European Paediatric Neurology Society
2016

Synthetic High-Density Lipoprotein-Like Nanocarrier Improved Cellular Transport of Lysosomal Cholesterol in Human Sterol Carrier Protein-Deficient Fibroblasts.

Journal of medicinal food
2016

Low bone mineral density is a common feature of Zellweger spectrum disorders.

Molecular genetics and metabolism
2015

First Japanese case of Zellweger syndrome with a mutation in PEX14.

Pediatrics international : official journal of the Japan Pediatric Society
2015

Zellweger spectrum disorders: clinical overview and management approach.

Orphanet journal of rare diseases
2015

Early Onset Hepatocellular Disease in an Infant with Zellweger Syndrome.

Acta medica Iranica
2015

Heimler Syndrome Is Caused by Hypomorphic Mutations in the Peroxisome-Biogenesis Genes PEX1 and PEX6.

American journal of human genetics
2015

Induced pluripotent stem cell models of Zellweger spectrum disorder show impaired peroxisome assembly and cell type-specific lipid abnormalities.

Stem cell research &amp; therapy
2016

Zellweger spectrum disorders: clinical manifestations in patients surviving into adulthood.

Journal of inherited metabolic disease
2015

Violent death in a rare peroxisomal disease--Zellweger syndrome.

Forensic science international
Ver todos os 333 no EuropePMC

Associações

Organizações que acompanham esta doença — pra ter apoio e orientação

Ainda não temos associações cadastradas para Síndrome Zellweger.

É de uma associação que acompanha esta doença? Fale com a gente →

Comunidades

Grupos ativos de quem convive com esta doença aqui no Raras

Ainda não existe comunidade no Raras para Síndrome Zellweger

Pacientes, familiares e cuidadores se organizam em comunidades pra compartilhar experiências, fazer perguntas e se apoiar. Você pode ser o primeiro.

Tire suas dúvidas

Perguntas, dicas e experiências compartilhadas aqui na página

Participe da discussão

Faça login para postar dúvidas, compartilhar experiências e interagir com especialistas.

Fazer login

Doenças relacionadas

Doenças com sintomas parecidos — ajudam quem ainda está buscando diagnóstico

Ordenadas pelo número de sintomas em comum.

Referências e fontes

Bases de dados externas citadas neste artigo

Publicações científicas

Artigos indexados no PubMed ligados a esta doença no grafo RarasNet — título, periódico e PMID direto da fonte, sem intermediação de IA.

  1. Dysregulated lipid metabolism and hypomyelination in postnatal peroxisome-deficient Pex2 knockout Zellweger mice.
    Frontiers in molecular neuroscience· 2026· PMID 41815956mais citado
  2. Identification of Potential Therapeutic Agents for Primary Amebic Meningoencephalitis Using Text Mining and Bioinformatics Analyses.
    Analytical cellular pathology (Amsterdam)· 2026· PMID 41810923mais citado
  3. Identification of a new frameshift homozygous variant of PEX3 gene in a preterm infant with profound global developmental delay and bilateral ptosis: a case report and updated literature review.
    BMC pediatrics· 2026· PMID 41495707mais citado
  4. What Peroxisomes (Don't) do to Mitochondria.
    Contact (Thousand Oaks (Ventura County, Calif.))· 2026· PMID 41623420mais citado
  5. New multiplex LC-MS/MS method for lipid biomarker analysis of inherited neurodegenerative metabolic diseases.
    Journal of lipid research· 2026· PMID 41429203mais citado

Bases de dados e fontes oficiais

Identificadores e referências canônicas usadas para montar este verbete.

  1. ORPHA:912(Orphanet)
  2. MONDO:0019609(MONDO)
  3. GARD:7917(GARD (NIH))
  4. Variantes catalogadas(ClinVar)
  5. Busca completa no PubMed(PubMed)
  6. Artigo Wikipedia(Wikipedia)
  7. Q189167(Wikidata)

Dados compilados pelo RarasNet a partir de fontes abertas (Orphanet, OMIM, MONDO, PubMed/EuropePMC, ClinicalTrials.gov, DATASUS, PCDT/MS). Este conteúdo é informativo e não substitui avaliação médica.

Conteúdo mantido por Agente Raras · Médicos e pesquisadores podem colaborar

Síndrome Zellweger
Compêndio · Raras BR

Síndrome Zellweger

ORPHA:912 · MONDO:0019609
Prevalência
Unknown
Herança
Autosomal recessive
CID-10
Q87.8 · Outras síndromes com malformações congênitas especificadas, não classificadas em outra parte
CID-11
Ensaios
2 ativos
Início
Neonatal
Prevalência
0.0 (Worldwide)
MedGen
UMLS
C0043459
Repurposing
1 candidato
cholic-acidbile acid
EuropePMC
Wikidata
Wikipedia
Papers 10a
Evidência
🥇 Rev. sistemática
DiscussaoAtiva

Nenhuma novidade ainda. O agente esta monitorando.

0membros
0novidades